International audienceAimsWith the explosion of anticancer drugs, an emerging concern is the risk for drug-induced sudden death (SD) via ventricular arrhythmias (VA).Methods and resultsWe used the international pharmacovigilance database VigiBase (n = 18 441 659 reports) to compare drug-induced long QT (diLQT, n = 18 123) and VA (n = 29 193) including torsade de pointes (TdP, n = 8163) reporting for 663 anticancer drugs vs. all other drugs until 01/01/2019. The analysis used the 95% lower-end credibility interval of the information component (IC025), an indicator for disproportionate Bayesian reporting; significant when IC025 >0. There were 2301 reports (13.8% fatal) for 40 anticancer drugs significantly associated with diLQT (with 27 also ...
Cardiac arrhythmias as an adverse reaction to the use of non-antiarrhythmic drugs have attracted muc...
Objective: Few data exist to guide antiarrhythmic drug therapy for sustained ventricular tachycardia...
Over the last decade, the advent of molecular targeted therapy radically changed the treatment of se...
International audienceAbstract Aims With the explosion of anticancer drugs, an emerging concern is t...
OBJECTIVES: To establish a unique sample of proarrhythmia cases, determine the characteristics of ca...
International audienceAims: The explosion of novel anticancer therapies has meant emergence of cardi...
Cardiovascular disease (CVD) remains the leading cause of death worldwide. An emerging contributory ...
Ventricular arrhythmias, including ventricular fibrillation (VF) and sustained ventricular tachycard...
Background: Ventricular dysrhythmias are a serious consequence associated with drug overdose and che...
The potentially life-threatening polymorphic ventricular arrhythmia Torsade de Pointes (TdP) general...
Almost 90% of patients resuscitated from out of hospital cardiac arrest have coronary heart disease ...
Antiarrhythmic therapy is known to be associated with a significant risk of adverse cardiac reaction...
Introduction: Cardiac injury is one of the most impairing side effects of anticancer treatment. The ...
The goal of drug development is to define potential risks and benefits of new therapies. Assessment ...
The article provides a scientific review based on the proceedings of the 2020 American Heart Associa...
Cardiac arrhythmias as an adverse reaction to the use of non-antiarrhythmic drugs have attracted muc...
Objective: Few data exist to guide antiarrhythmic drug therapy for sustained ventricular tachycardia...
Over the last decade, the advent of molecular targeted therapy radically changed the treatment of se...
International audienceAbstract Aims With the explosion of anticancer drugs, an emerging concern is t...
OBJECTIVES: To establish a unique sample of proarrhythmia cases, determine the characteristics of ca...
International audienceAims: The explosion of novel anticancer therapies has meant emergence of cardi...
Cardiovascular disease (CVD) remains the leading cause of death worldwide. An emerging contributory ...
Ventricular arrhythmias, including ventricular fibrillation (VF) and sustained ventricular tachycard...
Background: Ventricular dysrhythmias are a serious consequence associated with drug overdose and che...
The potentially life-threatening polymorphic ventricular arrhythmia Torsade de Pointes (TdP) general...
Almost 90% of patients resuscitated from out of hospital cardiac arrest have coronary heart disease ...
Antiarrhythmic therapy is known to be associated with a significant risk of adverse cardiac reaction...
Introduction: Cardiac injury is one of the most impairing side effects of anticancer treatment. The ...
The goal of drug development is to define potential risks and benefits of new therapies. Assessment ...
The article provides a scientific review based on the proceedings of the 2020 American Heart Associa...
Cardiac arrhythmias as an adverse reaction to the use of non-antiarrhythmic drugs have attracted muc...
Objective: Few data exist to guide antiarrhythmic drug therapy for sustained ventricular tachycardia...
Over the last decade, the advent of molecular targeted therapy radically changed the treatment of se...